Pretreatment 18F-FDG PET/CT-Derived Parameters in Predicting Clinical Outcomes of Locally Advanced Upper Third Esophageal Squamous Cell Carcinoma After Definitive Chemoradiation Therapy

被引：0
|
作者：
Le Ngoc Ha
Nguyen Dinh Chau
Bui Quang Bieu
Mai Hong Son
机构：
[1] Department of Nuclear Medicine,
[2] Department of Radiation Oncology and Radiosurgery,undefined
来源：
Nuclear Medicine and Molecular Imaging | 2022年 / 56卷
关键词：
F-FDG PET/CT; Standard uptake value; SUVmean; Prognosis; Esophageal squamous cell carcinoma; Definitive chemoradiotherapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：181 / 187
页数：6
相关论文
共 50 条
  • [21] Prognostic value of baseline 18F-FDG PET/CT in patients with esophageal squamous cell carcinoma treated with definitive (chemo)radiotherapy
    Lianshuang Xia
    Xiaoxu Li
    Jie Zhu
    Zhaisong Gao
    Ju Zhang
    Guangjie Yang
    Zhenguang Wang
    Radiation Oncology, 18
  • [22] Diffusion-weighted MRI and 18F-FDG PET/CT in assessing the response to neoadjuvant chemoradiotherapy in locally advanced esophageal squamous cell carcinoma
    Xu, Xin
    Sun, Zhi-Yong
    Wu, Hua-Wei
    Zhang, Chen-Peng
    Hu, Bin
    Rong, Ling
    Chen, Hai-Yan
    Xie, Hua-Ying
    Wang, Yu-Ming
    Lin, Hai-Ping
    Bai, Yong-Rui
    Ye, Qing
    Ma, Xiu-Mei
    RADIATION ONCOLOGY, 2021, 16 (01)
  • [23] Diffusion-weighted MRI and 18F-FDG PET/CT in assessing the response to neoadjuvant chemoradiotherapy in locally advanced esophageal squamous cell carcinoma
    Xin Xu
    Zhi-Yong Sun
    Hua-Wei Wu
    Chen-Peng Zhang
    Bin Hu
    Ling Rong
    Hai-Yan Chen
    Hua-Ying Xie
    Yu-Ming Wang
    Hai-Ping Lin
    Yong-Rui Bai
    Qing Ye
    Xiu-Mei Ma
    Radiation Oncology, 16
  • [24] Colonic Metastasis From Esophageal Squamous Cell Carcinoma Demonstrated With 18F-FDG PET/CT
    Fang, Na
    Wang, Yan-li
    Zeng, Lei
    Wu, Zeng-jie
    Liu, Li-li
    CLINICAL NUCLEAR MEDICINE, 2017, 42 (06) : 456 - 457
  • [25] 18F-FLT PET/CT in Predicting Response to Chemoradiotherapy in Esophageal Squamous Cell Cancer: Comparison with 18F-FDG PET/CT
    Chen, Haojun
    Guo, Wei
    Guo, Xiuyu
    Bing Hao
    Luo Nana
    Dan Ruan
    Long Sun
    Hua Wu
    JOURNAL OF NUCLEAR MEDICINE, 2018, 59
  • [26] Improved treatment outcomes with 18F-FDG PET/CT for patients with advanced head and neck squamous cell carcinoma
    Haerle, Stephan K.
    Soyka, M. B.
    Schmid, D. T.
    Ahmad, N.
    Huber, G. F.
    Crook, D. W.
    Hany, T. F.
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2012, 34 (09): : 1205 - 1211
  • [27] 18F-FDG PET/CT IN THE ASSESSMENT OF METABOLIC RESPONSE TO CHEMORADIATION THERAPY IN LOCALLY ADVANCED CERVICAL CANCER.
    Nam, E. J.
    Yoon, J. W.
    Kang, W. J.
    Yim, G. W.
    Kim, S. H.
    Kim, S. W.
    Kim, Y. T.
    Kim, J. W.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2014, 24 (09) : 1108 - 1108
  • [28] Significance of Posttreatment 18F-FDG PET/CT in Predicting Survival in Oropharyngeal Squamous Cell Carcinoma
    Nolan, N.
    Wright, C. L.
    Diavolitsis, V. M.
    Blakaj, D.
    McElroy, J. P.
    Grecula, J. C.
    Bhatt, A. D.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015, 93 (03): : E337 - E338
  • [29] Prognostic value of maximum standardized uptake value measured by pretreatment 18F-FDG PET/CT in locally advanced head and neck squamous cell carcinoma
    Cacicedo, J.
    Fernandez, I.
    del Hoyo, O.
    Navarro, A.
    Gomez-Iturriaga, A.
    Ignacio Pijoan, J.
    Martinez-Indart, L.
    Escudero, J.
    Gomez-Suarez, J.
    Ortiz de Zarate, R.
    Fernando Perez, J.
    Bilbao, P.
    Rades, D.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2017, 19 (11): : 1337 - 1349
  • [30] Prognostic value of maximum standardized uptake value measured by pretreatment 18F-FDG PET/CT in locally advanced head and neck squamous cell carcinoma
    J. Cacicedo
    I. Fernandez
    O. del Hoyo
    A. Navarro
    A. Gomez-Iturriaga
    J. Ignacio Pijoan
    L. Martinez-Indart
    J. Escudero
    J. Gomez-Suarez
    R. Ortiz de Zarate
    J. Fernando Perez
    P. Bilbao
    D. Rades
    Clinical and Translational Oncology, 2017, 19 : 1337 - 1349
12345